共 126 条
[1]
Lavanchy D(2004)Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J Viral Hepat 11 97-107
[2]
Mahoney FJ(1999)Update on diagnosis, management, and prevention of hepatitis B virus infection Clin Microbiol Rev 12 351-366
[3]
Lee WM(1997)Hepatitis B virus infection N Engl J Med 337 1733-1745
[4]
Lai CL(2003)Prevalence and clinical correlates of YMDD variants during lamivudine therapy of patients with chronic hepatitis B Clin Infect Dis 36 687-696
[5]
Dienstag J(1998)Identification and characterization of mutation in hepatitis B virus resistant to lamivudine Hepatology 27 1670-1677
[6]
Schiff E(2003)Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B N Engl J Med 348 808-816
[7]
Leung N(2003)Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B N Engl J Med 348 800-807
[8]
Atkins M(2004)Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus Gastroenterology 126 81-90
[9]
Hunt C(2004)Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic heaptitis B Gastroenterology 126 91-101
[10]
Allen MI(2006)Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years Gastroenterology 131 1743-1751